Article Information
History
- April 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Adrian Soto-Mota, MD, DPhil1,*,
- Braulio A. Marfil-Garza, CHRISTUS-LatAm Hub Center of Excellence and Innovation, MD1,
- Santiago Castiello de Obeso, MSc2,
- Erick Martínez, MD1,
- Daniel Alberto Carrillo-Vázquez, MD1,
- Hiram Tadeo-Espinoza, MD1,
- Jessica Paola Guerrero-Cabrera, MD1,
- Francisco Eduardo Dardón-Fierro, MD1,
- Juan Manuel Escobar Valderrama, MD1,
- Jorge Alanis-Mendizabal, MD1 and
- Juan Gutiérrez, MD, MSc1
- ↵*Corresponding author:
Luis Adrian Soto-Mota MD, DPhil. Assistant Professor at the Metabolic Diseases Research Unit of The National Institute of Medical Sciences and Nutrition Salvador Zubirán. Mexico City, Postal code: 14080., Tel: +52 5487 0900 ext.: 6321. Email: adrian.sotom{at}incmnsz.mx
Posted April 18, 2021.
Prospective predictive performance comparison between Clinical Gestalt and validated COVID-19 mortality scores
